Brief Communication abstract


Nature Genetics 39, 1071 - 1073 (2007)
Published online: 19 August 2007 | doi:10.1038/ng2107

Discovery of a previously unrecognized microdeletion syndrome of 16p11.2–p12.2

Blake C Ballif1, Sara A Hornor2, Elizabeth Jenkins3, Suneeta Madan-Khetarpal3, Urvashi Surti4,5, Kelly E Jackson6, Alexander Asamoah6, Pamela L Brock6, Gordon C Gowans6, Robert L Conway7, John M Graham, Jr7, Livija Medne8, Elaine H Zackai8, Tamim H Shaikh8, Joel Geoghegan9, Rebecca R Selzer9, Peggy S Eis9, Bassem A Bejjani1,2,10 & Lisa G Shaffer1,2

Top

We have identified a recurrent de novo pericentromeric deletion in 16p11.2–p12.2 in four individuals with developmental disabilities by microarray-based comparative genomic hybridization analysis. The identification of common clinical features in these four individuals along with the characterization of complex segmental duplications flanking the deletion regions suggests that nonallelic homologous recombination mediated these rearrangements and that deletions in 16p11.2–p12.2 constitute a previously undescribed syndrome.

Top
  1. Signature Genomic Laboratories, Spokane, Washington 99202, USA.
  2. Health Research and Education Center, Washington State University, Spokane, Washington 99210, USA.
  3. Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA.
  4. Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA.
  5. Magee-Womens Hospital, Pittsburgh, Pennsylvania 15213, USA.
  6. Weisskopf Child Evaluation Center, Louisville, Kentucky 40202, USA.
  7. Cedars-Sinai Medical Center, Los Angeles, California 90048, USA.
  8. The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA.
  9. NimbleGen Systems, Madison, Wisconsin 53711, USA.
  10. Sacred Heart Medical Center, Spokane, Washington 99204, USA.

Correspondence to: Lisa G Shaffer1,2 e-mail: lshaffer@wsu.edu


Extra navigation

Subscribe to Nature Genetics

Subscribe

naturejobs

natureproducts


ADVERTISEMENT